VSPharmTech is committed to a paradigm shift in the development of radiosensitizers by offering a mechanism-driven synergy-equipped radiosensitizer that excels in low toxicity, thus enabling its application across various types of tumors.
Read more ↓
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Tired of ads? Enjoy an ad-free experience by signing up.